Saturday 21 July 2012

Food And Drug Administration-Healthday News-Breast Cancer-Everolimus-Afinitor

Afinitor Approved for Advanced Breast Cancer

FRIDAY, July 20 (Healthday News) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday. read more..

No comments:

Post a Comment